INOVIO PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
INOVIO PHARMACEUTICALS, INC. (INO) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 284.09 thousand shares for the 3-month period ending 2018-09-30, per its 10-K filed 2019-03-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2019-03-12
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2018-09-30 was 284.09K shares.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2018-06-30 was 0.00 shares.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2018-03-31 was 0.00 shares.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2017-12-31 was 0.00 shares.
- INOVIO PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2017 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|---|
| 2018-09-30 | 284.09K shares 10-K · filed 2019-03-12 | 284.09K shares derived: sum of 2 quarters · filed 2019-03-12 | 284.09K shares derived: sum of 3 quarters · filed 2019-03-12 | 284.09K shares derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 0.00 shares 10-Q · filed 2018-08-07 | 0.00 shares derived: sum of 3 quarters · filed 2019-03-12 | 0.00 shares derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-09 | 0.00 shares derived: sum of 2 quarters · filed 2019-03-12 | 0.00 shares derived: sum of 3 quarters · filed 2019-03-12 | 0.00 shares derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 0.00 shares derived: sum of 2 quarters · filed 2019-03-12 | 0.00 shares derived: sum of 3 quarters · filed 2019-03-12 | 0.00 shares 10-K · filed 2019-03-12 |
| 2017-09-30 | 0.00 shares 10-Q · filed 2018-11-08 | 0.00 shares derived: sum of 2 quarters · filed 2018-11-08 | 0.00 shares 10-Q · filed 2018-11-08 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 0.00 shares 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-09 | |||
| 2016-09-30 | 0.00 shares 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |